Novosti
Khirurgii

 This journal is
indexed in Scopus
journal cover
android icon Android Applicaion
Ýòîò ñàéò èñïîëüçóåò îñíîâíûå ôàéëû cookie äëÿ îáåñïå÷åíèÿ åãî íîðìàëüíîé ðàáîòû è ôàéëû cookie äëÿ îòñëåæèâàíèÿ, ÷òîáû ïîíÿòü, êàê âû ñ íèì âçàèìîäåéñòâóåòå. Ïîñëåäíèå áóäóò óñòàíîâëåíû òîëüêî ïîñëå îäîáðåíèÿ.
Ñîãëàñèòüñÿ

Year 2010 Vol. 18 No 2

GENERAL AND SPECIAL SURGERY

SCHASTNY A.T., KUGAEV M.I.

SURGICAL TREATMENT OF CHRONIC PANCREATITIS WITH PRIMARY PANCREAS HEAD AFFECTION

Immediate postoperative treatment results of the patients with chronic pancreatitis with primary pancreas head affection are presented in the article. 201 patients (176 males, 25 females) were operated on. Beger’s operation was performed in 102 patients (50,7%), Bern’s variant of Beger’s operation in 27(13,5%), Fray’s operation in 13 (6,5%), pancreatoduodenal resection (PDR) in 59 (29,3%) patients. On the examination in the preoperative period, pain syndrome intensity didn’t differ much statistically in the patients with various complications and also didn’t depend on the width of the main pancreatic duct. Intraoperative hemotransfusion at PDR was significantly statistically greater than in other groups (ð<0,05). In the group of patients in whom PDR treatment was carried out in the HDU it was more lengthy than in other groups (ð<0,05). The number of complications was statistically much higher after pancreatoduodenal resection (66,1%) (ð<0,05).

Keywords: chronic pancreatitis, Beger’s operation, Fray’s operation, pancreatoduodenal resection
p. 27-36 of the original issue
References
  1. Fisher, B. Biological research in the evolution of cancer surgery: a personal perspective / B. Fisher Cancer Res. – 2008. – Vol. 68. – P. 10007-100020.
  2. Role of biopsy of signaling (“sentinel”) lymph nodes in the assessment of regional lymph collectors in patients with breast cancer / V. F. Semiglazov [et al.] // Vopr. Onkol. – 2002. – Vol. 48. – P. 106-109.
  3. Veronesi, U. Breast conservation: current results and future perspectives at the European Institute of Oncology / U. Veronesi, S. Zurrida // Int. J. Cancer 2007. – Vol. 120. – P. 1381-1386.
  4. Management of the axilla in operable breast cancer treated by breast conservation: a randomized clinical trial. Edinburgh Breast Unit / U. Chetty [et al.] // Br. J. Surg. – 2000. – Vol. 87. – P. 163-169.
  5. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer / B. Fisher [et al.] // N. Engl. J. Med. – 2002. – Vol. 347. – 1233-1241.
  6. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer / U. Veronesi [et al.] // N. Engl. J. Med. – 2002. – Vol. 347. – P. 1227- 1232.
  7. Breast cancer patients treated without axillary surgery: clinical implications and biologic analysis / M. Greco [et al.] // Ann. Surg. – 2000. – Vol. 232. – P. 1-7.
  8. Prospective observational study of sentinel lymphadenectomy without further axillary dissection in patients with sentinel node-negative breast cancer / A. E. Giuliano [et al.] // J. Clin. Oncol. – 2000. – Vol. 18. – P. 2553-2559.
  9. National practice patterns of sentinel lymph node dissection for breast carcinoma / A. Lucci [et al.] // J. Am. Coll. Surg. – 2001. – Vol. 192. – P. 453-458.
  10. Axillary metastases in breast cancer patients with negative sentinel nodes: a follow-up of 3548 cases / U. Veronesi [et al.] // Eur. J. Cancer. – 2009. – Vol. 45. – P. 1381-1388.
  11. Hieken, T. J. Selective or routine axillary disease staging for patients with clinically lymph nodenegative breast cancer? / T. J. Hieken, J. M. Velasco // Surgery. – 2006. – Vol. 140. – P. 500-507. – Disc. 7-8.
  12. T1a and T1b breast cancer: a twelve-year experience / T. J. Visser [et al.] // Am. Surg. – 1997. – Vol. 63. – P. 621-626.
  13. Prediction of additional axillary metastasis of breast cancer following sentinel lymph node surgery / C. Changsri [et al.] // Breast J. – 2004. – Vol. 10. – P. 392-397.
  14. Axillary lymph node dissection for T1a breast carcinoma. Is it indicated? / M. J. Silverstein [et al.] // Cancer. – 1994. – Vol. 73. – P. 664-667.
  15. Choi, S. H. Clinicopathologic analysis of sentinel lymph node mapping in early breast cancer / S. H. Choi, S. H. Barsky, H. R. Chang // Breast J. – 2003. – Vol. 9. – P. 153-162.
  16. Nonsentinel lymph node status after positive sentinel lymph node biopsy in early breast cancer / R. F. Saidi [et al.] // Am. Surg. – 2004. – Vol. 70. – P. 101-105. – Disc. 5.
  17. Kaptain, S. Her-2/neu and breast cancer / S. Kaptain, L. K. Tan, B. Chen // Diagn. Mol. Pathol. – 2001. – Vol. 10. – P. 139-152.
  18. Antitumor activity of HKI-272, an orally active, irreversible inhibitor of the HER-2 tyrosine kinase / S. K. Rabindran [et al.] // Cancer Res. – 2004. – Vol.64. – P. 3958-3965.
  19. The presence of an extensive intraductal component following a limited excision correlates with prominent residual disease in the remainder of the breast / R. Holland [et al.] // J. Clin. Oncol. – 1990. – Vol. 8. – P. 113-118.
  20. Schondorf, N. K. The technique of B-, S-, or Wreduction mammaplasty in the conservative therapy of breast carcinomas: experiences with a new surgical technique / N. K. Schondorf // Breast. – 2001. – Vol. 10. – P. 501-507.
  21. Kelley, M. C. Lymphatic mapping and sentinel lymphadenectomy for breast cancer / M. C. Kelley, N. Hansen, K. M. McMasters // Am. J. Surg. – 2004. – Vol. 188. – P. 49-61.
  22. Johansson, S. Dose response and latency for radiation-induced fibrosis, edema, and neuropathy in breast cancer patients / S. Johansson, H. Svensson, J. Denekamp // Int. J. Radiat Oncol. Biol. Phys. – 2002. – Vol. 52. – P. 1207-1219.
  23. What is the evidence for a reduced risk of local recurrence with age among older patients treated by breast conserving therapy? / I. H. Kunkler [et al.] // Breast. – 2001. – Vol. 10. – P. 464-469.
Contacts | ©Vitebsk State Medical University, 2007-2023